Avoid Pitfalls. Expedite Timelines. One Stop.
Drug discovery is a complicated process that requires experience to maneuver successfully. At Confluence Discovery Technologies (CDT), our full-service R&D team of drug discovery leaders will help you design and execute everything... from idea to IND.
We can help you navigate through key actions, including:
- strategy development
- problem solving
- assay design & validation
- project evaluation
- testing funnel design
- biomarker assessment
CDT uses experienced R&D scientists with years of drug discovery knowledge to evaluate the feasibility of your idea, testing funnel design and execution to bring your idea to IND and beyond.
Drug Discovery Research Process
You've got an idea for a new drug target that will meet an unmet medical need. The new drug program will need to pass through many stages before it reaches the Investigational New Drug (IND) filing.
CDT provides a complimentary consultation, helping you determine the path forward. Our experienced team can help guide you through each phase of the drug discovery research process, helping you avoid expensive pitfalls and eliminate time-wasting missteps.
Ready to find out more?
Drop us a line today for a complimentary consultation!
Expedited drug discovery timelines
When you know where the pitfalls are, you can avoid them. Our experienced researchers educate and guide you to develop, hone, then execute the studies on the path forward from idea to IND filing. This eliminates costly delays and time-consuming problems that inexperienced drug discovery researchers often encounter.
One stop research group integration
With our cross platform "Plug and Play” research integration, you get full service and customization. Our team works together with yours for coordinated evaluation and implementation. You gain integrated problem solving and strategic actions that add speed and flexibility to execution. And you don't have to find and manage numerous vendors for biochemistry, cell biology, chemistry, compound profiling, rodent PK, in vivo rodent efficacy studies, and more.
Drug Discovery Research Partners
The United States Food and Drug Administration's Investigational New Drug (IND) program reviews new drugs for safety to assure that research subjects will not be subjected to unreasonable risk. If the application is cleared, the candidate drug usually enters a Phase 1 clinical trial.
Our dedicated project managers foster a responsive collaborative learning environment with our clients adapting to meet the complexities of drug discovery. Our project managers leverage CDT’s robust internal research capabilities and strong CRO collaborations for our clients to provide seamless drug development processes through IND filing.